1815 (1815) Fair Value & Analysis

Consumer Cyclical · Market cap HK$845M

1 1815 1815 · HK

PriceHK$0.6100

Fair ValueHK$1.46

Upside+139.3%

Quality53/100

Watch 1815 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$1.15 – HK$1.82

Fair value as of: Jul 2, 2026

From 24 valuation models · updated today

Share price −26.5% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.6100 – HK$2.79 · fair‑value band HK$1.15 – HK$1.82 · the HK$0.6100 price screens below the HK$1.46 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1815 (1815) currently trades at HK$0.6100, while our model-based Fair Value estimate is HK$1.46 — implying the stock looks roughly 139.3% undervalued today. We read business quality at 53/100 (solid quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 1815 generated revenue of HK$487M at a net margin of 21.1%. It earns a return on equity of 4.3%. The balance sheet holds a net cash position of HK$492M. The stock trades on a trailing P/E of 10.2. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$487M

Revenue growth (YoY) +324%

Net margin 21.1%

Return on equity 4.3%

Free cash flow HK$136M FY2025

P/E ratio 10.2

More key figures

Operating margin 17.7%

EPS (TTM) HK$0.0300

Net cash HK$492M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1815 reported revenue of HK$487M in FY2025 versus HK$364M in FY2021, a compound +7.5%/yr. Reported net income was HK$103M in FY2025, compounding +516.8%/yr from FY2021.

Revenue +7.5%/yr

FY21 HK$364M

FY22 HK$1.8B

FY23 HK$410M

FY24 HK$158M

FY25 HK$487M

Net income +516.8%/yr

FY21 HK$71.0K

FY22 −HK$25.6M

FY23 −HK$35.0M

FY24 −HK$23.2M

FY25 HK$103M

Is 1815 fairly valued? → Check now

Similar stocks

6 more Luxury Goods stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
LVMH Moët Hennessy - Louis Vuitton, Société Européenne, LVMUY	$110.33	$105.81	-4%
Hermès International Société en commandite par actions HESAY	$202.49	$92.81	-54%
Compagnie Financière Richemont SA CFRHF	$226.16	$152.30	-33%
Christian Dior SE CHDRY	$125.90	$151.73	+21%
Titan Company TITAN	₹4,260	₹1,546	-64%
Kering SA PPRUF	$302.02	$68.89	-77%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1815 (1815) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$1.46 versus a price of HK$0.6100 — about +139% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1815?

Our model-based fair value for 1815 is HK$1.46 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.6100.

What is the quality score of 1815?

1815 has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1815 (1815)?

1815 reported trailing-twelve-month revenue of about HK$487M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1815?

The net profit margin of 1815 is about 21.1%, meaning it keeps roughly 21.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.